Etofenamate

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C18H18F3NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KZF0XM66JC, chemically known as 2-(2-hydroxyethoxy)ethyl-n-(alpha,alpha,alpha-trifluoro-m-tolyl)anthranilate but generally known as etofenamate, which bears US NIH Compound Identifier 35375. European Medicines Agency schedules Etofenamate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07319MIG. The term ETOFENAMATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, No. 10 1973, List 13). World Health Organization schedules etofenamate in its Anatomical Therapeutic Chemical (ATC) Classification. ETOFENAMATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule etofenamate under HS 29224995 and SITC 51465. As of Q4 2014, ETOFENAMATE remains the US FDA Preferred Term for this commodity. Etofenamate bears US NLM identifiers UMLS ID C0059868 and NCI Concept Code C80545. SMILES: FC(F)(F)C1CC(NC2C(CCCC2)C(=O)OCCOCCO)CCC1.